Orchestra BioMed Holdings, Inc. (OBIO)
Company Profile:
- Orchestra BioMed Holdings, Inc. is a biomedical innovation company in the healthcare sector.
- The company is based in New Hope, Pennsylvania and operates in the biotechnology industry.
- Its flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension, and Virtue Sirolimus AngioInfusion Balloon (SAB) for the treatment of atherosclerotic artery disease.
- Orchestra BioMed Holdings also develops FreeHold devices and minimally invasive surgery devices.
- The company has strategic collaborations with Medtronic and Terumo Corporation for the development and commercialization of its products.
- The leadership team includes Mr. David P. Hochman (Founder, Chairman of the Board of Directors & CEO) and Mr. Darren R. Sherman (Founder, President, COO & Director).
Financial Summary:
Support authors and subscribe to content
This is premium content. Subscribe to read the entire article.
Login if you have purchased
